NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$161.59
+0.68%
Tradestie Score
44
Market Cap
$254.99B
P/E Ratio
30.6
Revenue Growth
4.7%
Analyst Upside
-2.8%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$284.71
-0.36%
|
$448.07B | 43.0 | 47 | Compare |
|
ABBV
ABBVIE INC.
|
$295.95
+0.31%
|
$431.71B | 50.6 | 52 | Compare |
|
NVO
Novo-Nordisk A/S
|
$41.71
+0.19%
|
$262.92B | 10.4 | 42 | Compare |
|
AZN
AstraZeneca PLC
|
$184.92
+0.25%
|
$261.56B | 26.1 | 44 | Compare |
|
MRK
Merck & Co., Inc.
|
$146.35
-0.95%
|
$225.13B | 148.4 | 64 | Compare |
|
AMGN
Amgen Inc
|
$466.84
+0.25%
|
$160.70B | 27.1 | 47 | Compare |
|
PFE
Pfizer Inc.
|
$28.93
+0.14%
|
$154.70B | 41.2 | 56 | Compare |
|
GILD
Gilead Sciences Inc
|
$169.10
+0.60%
|
$137.92B | - | 47 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$48.61
+0.50%
|
$121.27B | 24.1 | 32 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$63.30
-0.21%
|
$96.54B | 13.8 | 56 | Compare |
More NVS Analysis
Data updated: Nov 16, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry